In-vivo studies on intraperitoneally administrated poly(vinyl alcohol)

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 93, Issue 1, 2010, Pages 275-284

  Jiang, Yanjiao ^a   Schädlich, Andreas ^a   Amado, Elkin ^a   Weis, Christine ^b   Odermatt, Erich ^b   Mäder, Karsten ^a   Kressler, Jörg ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b B Braun Melsungen AG   (Germany)

Author keywords

Fluorescence; In vivo imaging; Poly(vinyl alcohol); PVA; Urinary excretion

Indexed keywords

FTIR SPECTROSCOPY; IN-VIVO; IN-VIVO IMAGING; INTRAPERITONEAL; INTRAPERITONEALLY; NMR SPECTROSCOPY; NUDE MICE; PVA; SPECTROSCOPIC TECHNIQUE; TIME PERIODS; URINARY EXCRETION;

BODY FLUIDS; DIALYSIS; FLUORESCENCE; FOURIER TRANSFORM INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SIZE EXCLUSION CHROMATOGRAPHY;

ORGANIC POLYMERS;

BILIRUBIN; POLYVINYL ALCOHOL; TETRAMETHYLRHODAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; DIALYSIS; FEMALE; FLUORESCENCE IMAGING; FOURIER ANALYSIS; GEL PERMEATION CHROMATOGRAPHY; GLOMERULUS FILTRATION; IN VIVO STUDY; INFRARED SPECTROSCOPY; METABOLITE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; URINALYSIS; URINARY EXCRETION; URINE COLOR;

ANIMALS; BIOCOMPATIBLE MATERIALS; FEMALE; FLUORESCENT DYES; INJECTIONS, INTRAPERITONEAL; KIDNEY; MAGNETIC RESONANCE SPECTROSCOPY; MATERIALS TESTING; MICE; MICE, NUDE; POLYVINYL ALCOHOL; RABBITS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TISSUE DISTRIBUTION;

EID: 77949516665     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31585     Document Type: Article

References (53)

1. Cosmetic Ingredient Review (CIR). Final report on the safety assessment of polyvinyl alcohol. Int J Tox 1998;17:67-92.
2. Paradossi G, Cavalieri F, Chiessi E, Spagnoli C, Cowman MK. Poly(vinyl alcohol) as versatile biomaterial for potential biomedical applications. J Mater Sci Mater Med 2003;14:687-691.
3. Oka M, Naguchi T, Kumar P, Ikeuchi K, Yamamuno T, Hyon SH, Ikada Y. Development of an artificial articular cartilage. Clin Mater 1990;6:361-381.
4. Yamaoka T, Tabata Y, Ikada Y. Accumulation of poly(vinyl alcohol) at inflammatory site. In: Ottenbrite RM, editor. ACS Symposium Series No. 545: Polymeric Drugs and Drug Administration. Washington, DC: American Chemical Society; 1994. pp 163-171.
5. Noguchi T, Yamamuro T, Oka M, Kumar P, Kotoura Y, Hyon SH, Ikada Y. Poly(vinyl alcohol) hydrogel as an artificial articular cartilage: Evaluation of biocompatibility. J Appl Biomater 1991;2:101-107.
6. Kaetsu I. Radiation synthesis of polymeric materials for biomedical and biochemical applications. Adv Polym Sci 1993;105:81-97.
7. Nambu M. U.S. Pat. No. 4,472,542; 1984.
8. Hyon SH, Ikada Y. U.S. Pat. No. 4,663,358; 1987.
9. Hassan CM, Peppas NA. Cellular PVA hydrogels produced by freeze/thawing. J Appl Polym Sci 2000;76:2075-2079.
10. Hyon SH, Cha WI, Ikada Y, Kita M, Ogura Y, Honda Y. Poly(vinyl alcohol) hydrogels as soft contact lens material. J Biomat Sci Polym Ed 1994;5:397-406.
11. Devlin BG, Tena M, Medina NA. U.S. Pat Appl Publ, US 2005056954 A1 2005031; 2005.
12. Kobayashi M, Chang YS, Oka M. A two year in vivo study of polyvinyl alcohol-hydrogel (PVA-H) artificial meniscus. Biomaterials 2005;26:3243-3248.
13. Bray JC, Merril EW. Poly(vinyl alcohol) hydrogels for synthetic articular cartilage material. J Biomed Mater Res 1973;7:431-443.
14. Bao QB, Higham PA. U.S. Pat. No. 5,047,055; 1991.
15. Maluccio MA, Covey AM, Porat LB, Schubert J, Brody LA, Sofocleous CT, Getrajdman G I, Jarnagin W, Dematteo R, Blumgart LH. Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radio 2008;19:862-829.
16. Sharma CP. Surface modification: tissue compatibility towards the development of artificial skin. ICMR Project Report 1989.
17. Peppas NA, Benner RE Jr. Proposed method of intracopdal injection and gelation of poly (vinyl alcohol) solution in vocal cords: Polymer considerations. Biomaterials 1980;1:158-162.
18. Lozinsky VI, Plieva FM, Galaev IY,Mattiasson B. The potential of polymeric cryogels in bioseparation. Bioseparation 2001;10:163-188.
19. Chase HA. Purification of proteins by adsorption chromatography in expanded beds. Trends Biotechnol 1994;12:296-303.
20. Mallapragada SK, Peppas NA. Dissolution mechanism of semi-crystalline poly(vinyl alcohol) in water. J Polym Sci Part B: Polym Phys 1998;34:1339-1346.
21. Takamura A, Ishii F, Hidaka H. Drug release from poly(vinyl alcohol) gel prepared by freeze-thaw procedure. J Control Rel 1992;20:21-28.
22. Peppas NA, Scott JE. Controlled release from poly(vinyl alcohol) gels prepared by freezing-thawing processes. J Control Rel 1992;18:95-100.
23. Qiu Y, Park K. Environment-sensitive hydrogels for drug delivery. Adv Drug Del Rev 2001;53:321-339.
24. Langer R, Folkman J. Polymers for the substained release of proteins and other macromolecules. Nature 1976;263:797-800.
25. Peppas NA, Mongia NK. Ultrapure poly(vinyl alcohol) hydrogels with mucoadhesive drug delivery characteristics. Eur J Pharm Biopharm 1997;43:51-58.
26. Weis C, Odermatt E, Kressler J, Funke Z, Wehner T, Freytag D. Poly(vinyl alcohol) membranes for adhesion prevention. J Biomed Mater Res B 2004;70:191-202.
27. Weis C, Odermatt Erich K. A-Part gel - An efficient adhesion prevention barrier. J Biomed Mat Res Part B: Appl Biomater 2007;82B:174-182.
28. DeMerlis CC, Schoneker DR. Review of the oral toxicity of polyvinyl alcohol (PVA). Food Chem Toxicol 2003;41:319-326.
29. Hall CE, Hall O. Polyvinyl alcohol nephrosis: Relationship of degree of polymerization to pathophysiological effects. Proc Soc Exp Bio Med 1963;112:86-91.
30. Kaneo Y, Hashihama S, Kakinoki A, Tanaka T, Nakano T, Ikeda Y. Pharmacokinetics and biodisposition of poly (vinyl alcohol) in rats and mice. Drug Metabol Pharmacokin 2005;20:435-442.
31. Lukas G, Brindle S, Greengard P. The route of absorption of intraperitoneally administrated compounds. J Pharmacol Exp Ther 1971;178:562-566.
32. Yamaoka T, Tabata Y, Ikada Y. Fate of water - Soluble polymers administered via different routes. J Pharma Sci 1995;84:349-354.
33. Tabata Y, Murakami Y, Ikada Y. Tumor accumulation of poly(vinyl alcohol) of different sizes after intravenous injection. J Control Rel 1998;50:123-133.
34. Venturoli D, Rippe B. Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: Effects of molecular size, shape, charge and deformability. Am J Physiol Renal Physiol 2005;288:605-613.
35. Bohrer MP, Deen WM, Robertson CR, Troy JL, Brenner BM. Influence of molecular configuration on the passage of macromolecules across the glomerular capillary wall. J Gen Physiol 1979;74:583-593.
36. Ohlson M, Sorensson J, Lindstrom K, Blom AM, Fries E, Haraldsson B. Effects of filtration rate on the glomerular barrier and clearance of four differently shaped molecules. Am J Physiol Renal Physiol 2001;281:103-113.
37. Yamaoka T, Tabata Y, Ikada Y. Comparison of body distribution of poly(vinyl alcohol) with other water-soluble polymers after intravenous administration. J Pharm Pharmacol 1995;47:479-486.
38. Silbernagl S, Despopoulos A. Kidney. Taschenatlas der Physiologie. Stuttgart: Thieme; 2007. p 148.
39. Besheer A, Maeder K, Kaiser S, Kressler J, Weis C, Odermatt EK. Tracking the urinary excretion of high molar mass poly(vinyl alcohol). J Biomed Mat Res Part B: Appl Biomater 2007;82:383-389.
40. Yamaoka T, Tabata Y, Ikada Y. Body distribution of intravenously administered gelatin with different molar masses. J Control Rel 1994;31:1-8.
41. Kaneo Y, Nakano T, Tanaka T, Tamaki R, Iwase H, Yamaguchi Y. Characteristic distribution of polysaccharides in liver tissue. Yakuzaigaku 2000;60:183-195.
42. Matsumura S, Steinbüchel A. Miscellaneous Biopolymers and Biodegradation of Synthetic Polymers, Vol. 9. Weinheim, Germany: Wiley-VCH; 2003. pp 329-361.
43. Kawai F. Xenobiotic polymers. In: Imanaka T, editor. Great Development of Microorganisms. Tokyo: NTS; 2002. pp 865-870.
44. Matsumura S, Tomizawa N, Toki A, Nishikawa K, Toshima K. Novel poly(vinyl alcohol)-Degrading enzyme and the degradation mechanism. Macromolecules 1999;32:7753-7761.
45. Chiellini E, Corti A, D'Antone S, Solaro R. Biodegradation of poly(vinyl alcohol) based materials. Prog Polym Sci 2003;28:963-1014.
46. Levenson ML, Mansfield JR. Multispectral imaging in biology and medicine: Slices of life. Cytometry A 2006;69:748-758.
47. He X, Nie H, Wang K, Tan W, Wu X, Zhang P. In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles. Anal Chem 2008;80:9597-9603.
48. Raymond SB, Skoch J, Hills ID, Nesterov EE, Swager TM, Bacskai BJ. Smart optical probes for near-infrared fluorescence imaging of Alzheimer's disease pathology. Eur J Nucl Med Mol Imaging 2008;35:93-98.
49. Watson CJ. Recent studies of the urobilin problem. J Clin Pathol 1963;16:1-11.
50. Yang Z, Si S, Fung Y. Bilirubin adsorption on nanocrystalline titania films. Thin Solid Films 2007;515:3344-3351.
51. Yang B, Taylor RC, Morris MD, Wang X, Wu J, Yu B, Xu G, Soloway RD. Normal coordinate analysis of bilirubin vibrational spectra: effects of intramolecular hydrogen bonding. Spectrochim Acta Part A: Mol Biomed Spec 1993;49:1735-1749.
52. Wang Y, Ono H, Ikeda A, Hori N, Takemura A, Yamada T, Tsukatani T. 1H NMR and 13C NMR investigations of sequence distribution and tacticity in poly(vinyl alcohol-co-vinyl levulinate). Polymer 2006;47:7827-7834.
53. Marstokk O, Roots J. Synthesis and characterization of hydrophobically modified poly(vinyl alcohol). Polym Bull 1999;42: 527-533.